Latest News & Features
Big Pharma
A division of Novartis has entered into an agreement with Taiwan-based EirGenix to market a medicine which treats some cancer tumours. 1 May 2019
Asia
PepsiCo India is attempting to settle a lawsuit against four Indian farmers who the food and drink company say infringed its IP by growing a protected variety of potato. 30 April 2019
Americas
The US Court of Appeals for the Federal Circuit has rejected Medtronic’s attempt to revisit a ruling that lumbered the medical device company with a $23 million loss. 30 April 2019
Americas
The US Court of Appeals for the Federal Circuit affirmed a series of Patent Trial and Appeal Board inter partes reviews, which upheld a patent owned by Eli Lilly late last week. 29 April 2019
Americas
The six antitrust class-action lawsuits that have been brought against AbbVie could result in more scrutiny of settlement agreements between the innovator and the biosimilar manufacturer, with potential antitrust complications. 29 April 2019
Americas
US courts need to revisit the patentability of diagnostic tests under section 101, according to Memorial Sloan Kettering Cancer Center’s chief IP counsel. 26 April 2019
Americas
Petitioners will continue to be able to launch litigation simultaneously before both the district court and the Patent Trial and Appeal Board, effectively having two bites at the apple, according to John Kirkland, director of IP at biopharmaceutical company Alkermes. 26 April 2019
Americas
There’s alarm in the scientific community because of how broadly the principles of the Mayo test for section 101 are being used to strike down patents on profound innovations and discoveries. 26 April 2019
Big Pharma
The Delhi High Court has cleared two Indian drug companies to export a cancer drug and blood thinner, both patented by Bayer, for the purposes of development and clinical trials for regulatory clearances. 25 April 2019
Big Pharma
Biotech and pharmaceutical companies have submitted an amicus brief urging an appeals court to rethink a ruling, which invalidated a patent exclusively licensed by Athena Diagnostics. 25 April 2019